{
    "2019-09-24": [
        [
            {
                "time": "2023-03-15",
                "original_text": "Moody's announces completion of a periodic review of ratings of Novo Nordisk A/S",
                "features": {
                    "keywords": [
                        "Moody's",
                        "ratings",
                        "Novo Nordisk"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "How Novo Nordisk Is Aiming To Take A Slice Of Lilly's Diabetes Market",
                "features": {
                    "keywords": [
                        "Novo Nordisk",
                        "Lilly",
                        "Diabetes Market"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "What The Price Tag Says About Novo Nordisk's Newest Diabetes Drug",
                "features": {
                    "keywords": [
                        "Price Tag",
                        "Novo Nordisk",
                        "Diabetes Drug"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-03-15",
                "original_text": "Bristol-Myers Squibb Company -- Moody's: China's rising demand for drugs will fuel foreign pharma companies' growth into 2023",
                "features": {
                    "keywords": [
                        "Bristol-Myers Squibb",
                        "China",
                        "demand",
                        "drugs",
                        "growth"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}